A guy studying improv, flow, psychedelics, and creativity 🧠 🍄 🎵 | Postdoc @JHPsychedelics | Dad, Bassist, Pianist, Yogi, Educator
Joined February 2018
- Tweets 1,056
- Following 851
- Followers 823
- Likes 2,619
50 Photos and videos
Pinned Tweet
1 Mar 2024
NEW RESEARCH: The Neuroscience of Creative Flow in Jazz Improvisation: An EEG Study 🧠 🎵 🗣️
Delve into the secrets of creative flow in jazz improvisation and how experience affects these altered states of consciousness.
Read the full paper here: sciencedirect.com/science/ar…
4
24
73
13,899
6 Dec 2025
RT @sapinker: Me:
I try to look at data and trends rather than headlines, because headlines can give you a misleading picture of the state…
172
5 Dec 2025
🌀 New paper out from @JHPsychedelics led by @CeydaSayali.
Psychedelics loosen cognitive control acutely and selectively increase cognitive flexibility afterwards.
Flexibility is the ability to shift perspectives, update beliefs, and break rigid patterns.
DM for PDF.
In our new review, we synthesize behavioral and neuroimaging evidence showing that psychedelics induce a time- and domain-specific modulation of executive function. Acutely, psychedelics disrupt executive functions alongside destabilized brain network dynamics. Post-acutely, they selectively enhance cognitive flexibility with increased activation and connectivity in executive brain networks. While promising, evidence remains limited and future studies must clarify which cognitive effects drive clinical outcomes.
1
4
212
David S. Rosen, PhD retweeted
19 Nov 2025
There is actually something cognitively beneficial to microdosing classic psychedelics (beyond placebo) that the scientific method just hasn’t yet been able to detect.
37%
Yes
63%
No
19 votes • Final results
1
2
4
295
David S. Rosen, PhD retweeted
19 Nov 2025
Can you believe Empyrean Isles was released 61 years ago this month? We sure can’t! 🤯
25
91
760
20,249
David S. Rosen, PhD retweeted
19 Nov 2025
People on psychedelics during a mass-trauma event (Nova rave) reported that psychedelic effects suddenly went away completely and they felt clear and calm. After they reached safety, these survivors described resurgance of vivid hallucinations! The researchers are calling it 'Adaptive dissociation'.
An interesting twist on our observation that psychedelic effects are highly context-dependent. When you focus on a task, effects decreased markedly, with stronger effects returning when attention relaxes.
👉 Read about the link: psychologytoday.com/us/blog/…
24
33
298
16,428
David S. Rosen, PhD retweeted
18 Nov 2025
Check out this awesome new work by Tuval! Providing critical empirical evidence on question asking, knowledge acquisition, and academic assessments
🚀New research alert
Check out our new preprint exploring how students’ question-asking changes as they gain relevant knowledge, and why this matters for the future of education.
@yoed_kenett
osf.io/preprints/psyarxiv/ah…
1
1
153
David S. Rosen, PhD retweeted
🚨ATTN: Society for Neuroscience attendees @SfNtweets 🚨
We are hosting a pre-SfN event: "The Trip between Bedside and Bench: Advancing Cross-Species Translation in Psychedelic Neuroscience"
Registration is limited - reserve your spot ASAP! Share with anyone who might be interested! hopkinspsychedelic.org/sfn20…
1
10
14
6,005
David S. Rosen, PhD retweeted
Check out the latest primer in NPP-Digital Psychiatry and Neuroscience (@dpn_journal), where Dr. Albert Garcia-Romeu explores key debates and unresolved questions in the rapidly evolving field of psychedelic therapy and research.
nature.com/articles/s44277-0…
5
14
1,645
26 Aug 2025
Looking forward to this excellent pre-#SfN25 event from @JHPsychedelics 👇 A rare chance to dive into cross-species translation in psychedelic neuroscience with leading voices in the field. 🍄 Seats are limited—don’t miss it!
26 Aug 2025
🚨ATTN: @SfNtweets attendees🚨
@JHPsychedelics is hosting a pre-SfN event: "The Trip between Bedside and Bench: Advancing Cross-Species Translation in Psychedelic Neuroscience"🍄
Registration is limited - reserve your spot ASAP! hopkinspsychedelic.org/sfn20…
RTs appreciated! Info👇
3
153
David S. Rosen, PhD retweeted
Associate Director, Dr. Albert Garcia-Romeu shared his insights on psychedelic therapies for psychiatric disorders. He explains the science, shifting public perception, and potential for future FDA approval for these therapies.
4
21
70
5,126
David S. Rosen, PhD retweeted
14 Jul 2025
Are you an early-career cognitive neuroscientist, looking to contribute to a new line of research?
The Frontlab at Paris Brain Institute is seeking a postdoctoral researcher to work on a state-of-the-art creativity neuroscience project -
offres.institutducerveau-icm…
3
7
545
7 Jul 2025
🎸 Mike Gordon’s XenboX is one of the most exciting neuro/music collaborations I’ve seen.
A real-time system to detect and enhance flow in musicians?
Yes, please. As a musician, neuroscientist & lifelong Phish fan, I had to weigh in.
🔗 rollingstone.com/music/music…
#phish #flow
2
2
6
282
7 Jul 2025
XenboX is bold and inspiring.
But understanding and scaling tools for creative flow will require more science—across domains, in the wild, and with personalized models of set and setting.
This deeper inquiry is similar to questions we are pursuing in psychedelic science.
1
46
7 Jul 2025
Huge kudos to @mike_gordon & the XenboX team. Merging music, brain tech, and performance science is rare—and visionary.
Maybe one day I'll have a chance to help advance this project 🤞
#creativity #music #improvisation #neurofeedback #phish #DMN #braintech #peakperformance
61
David S. Rosen, PhD retweeted
5 Jul 2025
A teacher in Thailand invites her students to pick their greeting.
Can we do this in every classroom in every country?
62
202
1,488
223,192
30 Jun 2025
My mentors and colleagues representing on Capitol Hill.
What an honor to be a part of the CPCR!
Last week, CPCR researchers Drs. Fred Barrett, Brandon Weiss, David Yaden, and Sandeep Nayak met with the PATH Caucus (led by @RepLouCorrea and @RepJackBergman) on Capitol Hill. In a vibrant meeting of oral presentations and Q&A, Drs. Barrett and Weiss shared their scientific findings signaling the potential for Psilocybin Therapy to be a rapid-acting, efficacious, safe, and tolerable tool for treating PTSD, alcohol use disorder, and depression among military Veterans and other Americans. We thank the PATH Caucus for their great advocacy for research on psychedelic therapy and Veteran health, and for including us in their mission.
@FredBarrettPhD @BWe1ss @ExistWell @sdpnayak
3
102